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nal tubular reabsorption is important for extracellular fluid homeostasis
and much of this occurs via the receptor-mediated endocytic pathway.
This pathway is disrupted in Dent’s disease, an X-linked renal tubular
disorder that is characterized by low-molecular-weight proteinuria, hy-
percalciuria, nephrolithiasis, and renal failure. Dent’s disease is due to
mutations of CLC-5, a chloride/proton antiporter, expressed in endo-
somes and apical membranes of renal tubules. Loss of CLC-5 function
alters receptor-mediated endocytosis and trafficking of megalin and
cubilin, although the underlying mechanisms remain to be elucidated.
Here, we report that CLC-5 interacts with kinesin family member 3B
(KIF3B), a heterotrimeric motor protein that facilitates fast anterograde
translocation of membranous organelles. Using yeast two-hybrid, gluta-
thione-S-transferase pull-down and coimmunoprecipitation assays, the
COOH terminus of CLC-5 and the coiled-coil and globular domains of
KIF3B were shown to interact. This was confirmed in vivo by endoge-
nous coimmunoprecipitation of CLC-5 and KIF3B and codistribution
with endosomal markers in mouse kidney fractions. Confocal live cell
imaging in kidney cells further demonstrated association of CLC-5 and
KIF3B, and transport of CLC-5-containing vesicles along KIF3B micro-
tubules. KIF3B overexpression and underexpression, using siRNA, had
reciprocal effects on whole cell chloride current amplitudes, CLC-5 cell
surface expression, and endocytosis of albumin and transferrin. Clcn5Y/
mouse kidneys and isolated proximal tubular polarized cells showed
increased KIF3B expression, whose effects on albumin endocytosis were
dependent on CLC-5 expression. Thus, the CLC-5 and KIF3B interaction
is important for CLC-5 plasma membrane expression and for facilitating
endocytosis and microtubular transport in the kidney.
chloride/proton antiporter; kinesin family; proximal tubular reabsorp-
tion; hypercalciuric nephrolithiasis; receptor-mediated endocytosis
THE RECEPTOR-MEDIATED ENDOCYTIC pathway (RMEP) plays an
important role in facilitating renal tubular reabsorption and
hence maintaining extracellular fluid homeostasis (4). This
pathway is disrupted in Dent’s disease (OMIM: 300009), an
X-linked renal tubular disorder characterized by low-molecu-
lar-weight proteinuria, hypercalciuria, nephrolithiasis, and pro-
gressive renal failure (28, 37). Dent’s disease is usually caused
by mutations in a chloride/proton antiporter, CLC-5 (GenBank
accession number NM_001127899.1), and mice deleted for a
Clcn5 allele develop the renal tubular defects associated with
Dent’s disease (37, 45, 47, 48, 55).
CLC-5 belongs to the nine-member family of CLC proteins
(CLC-1 to CLC-7, CLC-Ka, and CLC-Kb), which include
voltage-gated chloride channels and chloride/proton antiport-
ers that are found at the plasma membrane and membranes of
intracellular organelles. CLCs have diverse functions, which
include the control of membrane excitability, the regulation of
cell volume, and transepithelial transport (28). For example,
CLC-5, which is an antiporter expressed at multiple sites in the
human nephron, including the proximal tubules (PT), the thick
ascending limb (TAL) of the loop of Henle, and the -inter-
calated cells of the collecting duct (CD), is involved in trans-
epithelial solute transport (e.g., the RMEP of the PT cells) and
is localized primarily in early endosomes and apical (luminal)
membranes of renal PT (7, 16, 49). Disruption of Clcn5 in mice
leads to defective fluid-phase and receptor-mediated endocy-
tosis, by the renal PT, indicating that CLC-5 contributes to
endocytosis in vivo (4, 16, 47, 55). Indeed, the renal tubular
abnormalities observed in patients with Dent’s disease, which
is caused by mutations in CLC-5, are consistent with a func-
tional loss of CLC-5 in such reabsorptive pathways (7, 16).
Furthermore, these renal abnormalities have been shown to
result from altered receptor-mediated endocytosis in associa-
tion with defective trafficking of the megalin and cubilin
receptor complex (4).
The role of CLC-5 in endosomal trafficking remains to be
established. Loss of CLC-5 function leads to impaired endo-
somal acidification which may contribute to the observed
defects in endosomal trafficking (4). Interestingly, pharmaco-
logical inhibition of vacuolar acidification has been reported to
decrease endosomal recycling and transfer to lysosomes (1) but
not the rate of endocytosis, consistent with a trafficking defect
(6, 52). Any possible role of CLC-5 in endosomal transport is
likely to involve the CLC-5 COOH terminus (amino acids 551
to 746; Fig. 1A) as this has been shown to be cytoplasmic by
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Fig. 1. Interactions between CLC-5 and KIF3B subunits. A: CLC-5 consists of 18 helices (A to R) with the NH2- and COOH-terminus (C-term) domains being
cytoplasmic (membrane boundaries indicated by arrows) (10, 58). B: yeast 2-hybrid using the CLC-5 C-term, which contains 2 CBS domains (11) to screen a
renal cDNA library, identified KIF3B as a putative interactor. Interaction between large T and p53 provided a positive control. C: 35S-methionine-labeled CLC-5
C-term was incubated with GST-tagged KIF3B coiled coil (CC)/globular domain (GD). Resin-bound proteins were resolved by SDS-PAGE and detected by
autoradiography. Results from 2 independent in vitro translation experiments using 2 different GST-tagged KIF3B clones are shown. The larger band at 24.5
kDa represents the 216 amino acid Myc-tagged CLC-5 C-term, whereas the smaller band at18.5 kDa likely represents another translated form of CLC-5 C-term
that originated from use of an alternative methionine at codon 583 and hence lacked the NH2 terminal 32 amino acids. This smaller CLC-5 C-term, which was
less efficiently translated, had both CBS domains and hence was pulled down by the GST-tagged KIF3B CC/GD. D: endogenous coimmunoprecipitation using
wild-type mouse whole kidney extracts and a KIF3B monoclonal antibody (mAb). KIF3B, KIF3A, and KAP3 mAb were used to confirm endogenous
coimmunoprecipitation of these proteins which form a trimeric complex. It is important to note that the interaction between CLC-5 and KIF3B is likely to be
transient, as endosomes will be released to continue recycling, and that only a small proportion of the total cellular CLC-5 will be present, at a given time point,
on the surface of endosomes that are being trafficked anterogradely; these features are consistent with the relatively low amount of KIF3B that is
immunopreciptiated by CLC-5. E: coimmunoprecipitation studies using HEK293 cells demonstrated interactions between CLC-5 and KIF3B domains. Lane 1:
input; lanes 2, 3, and 4: pull-down with no antibody, anti-Myc, or anti-HA antibodies, respectively. F: summary of KIF3B domains showing presence () or
absence () of interactions with CLC-5. G: coimmunoprecipitation studies using HEK293 cells demonstrated interactions between CLC-4 and KIF3B, and
CLC-7 and KIF3B. Lane 1: input; lanes 2, 3, and 4: pull-down with no antibody, anti-Myc, or anti-HA antibodies, respectively.
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an analysis of the three-dimensional structures of homologous
bacterial CLCs (10, 58). Moreover, the COOH terminus con-
tains potential binding motifs for regulatory molecules: these
include two cystathionine--synthase (CBS1 and CBS2) do-
mains, a PY motif (PPLPPY), and a putative PDZ-binding
motif (11, 25, 49). Indeed, a number of proteins, including
CLC-4, cofilin, WWP2, Nedd4-2, and Na-H exchanger
regulatory factor 2 (NHERF2), have been reported to interact
with CLC-5.
CLC-4, which is expressed in endosomes, contributes to
endosomal acidification and trafficking by forming a complex
with CLC-5 (39, 40). Cofilin, which is an actin depolymerizing
protein, interacts with the COOH terminus of CLC-5, and
phosphorylation of cofilin is associated with reduced albumin
uptake (26). WWP2, which binds strongly to the PY motif of
CLC-5, belongs to the same protein class as the ubiquitin-
protein ligase Nedd4-2 that has also been demonstrated to
interact with the COOH terminus of CLC-5 and to alter CLC-5
currents by decreasing the cell surface expression of CLC-5
(24, 46, 49). CLC-5, whose cell surface expression increases in
opossum kidney (OK) cells that are exposed to albumin,
undergoes ubiquitination and a reduction in Nedd4-2 is accom-
panied by decreased albumin uptake in OK cells. These results
indicate that Nedd4-2 may act via ubiquitination to shunt
CLC-5 into the endocytic pathway (24). NHERF2, which is an
epithelial PDZ scaffold that interacts with and alters the cell
surface levels of CLC-5, links CLC-5 to ezrin and anchors the
endocytic complex (23). However, the mechanisms whereby
CLC-5 affects endosomal transport within the RMEP remain to
be elucidated. We therefore used the CLC-5 COOH-terminus
domain (Fig. 1A) as bait to perform a yeast two-hybrid
screen of an adult human renal cDNA library with the aim
of identifying interacting proteins involved in the endocytic
pathway (4, 7).
MATERIALS AND METHODS
Yeast two-hybrid analysis. Partial CLC-5 cDNAs that encode the
COOH terminus (C-term; peptides 551–746), CBS1 (peptides 576–
680), and CBS2 (peptides 674–746) were subcloned into pGBKT7,
containing the Gal4 DNA binding domain (BD) to generate bait
plasmids. Yeast strain PJ69-2A transformed with pGBKT7-CLC-5
(C-term) was used to screen a Matchmaker pretransformed adult
human kidney cDNA library in Y187 yeast strain, according to the
manufacturer’s instructions (BD Bioscience) (42). The DNA se-
quences of prey plasmids isolated from positive clones were analyzed
using a gapped BLAST search of NCBI databases. To confirm the
interaction, prey plasmids were retransformed into PJ69-2A contain-
ing pGBKT7-CLC-5 (C-term) or pGBKT7 and tested for growth on
selective plates (42). pGBKT7-p53 and pGADT7-Large T antigen
were used as positive controls (42). KIF3B (FL) was subcloned into
pACT2 containing the Gal4 activation domain. All inserts were
confirmed by DNA sequence analysis (42). PJ69-2A was transformed
sequentially with the appropriate CLC-5 and KIF3B constructs and
monitored for growth on selective plates (42). Expression of CLC-5
and KIF3B Gal4 fusion proteins in yeast was confirmed by Western
blot analysis using anti-HA (pACT2-KIF3B) or anti-Myc (pGBKT7-
CLC-5) antibodies (42).
Glutathione-S-transferase fusion protein and pull-down assay.
KIF3B CC/GD was subcloned into pGEX-4T-1 and expressed in
Escherichia coli BL21 (42). 35S-labeled CLC-5 (C-term) protein was
prepared by in vitro transcription/translation using pGBKT7-CLC-5
(C-term; TNT System, Promega, Madison, WI). Glutathione-S-trans-
ferase (GST)-pulldowns of GST-KIF3B and radiolabeled CLC-5
(C-term) proteins were performed as previously described (42).
Coimmunoprecipitations. Full-length CLC-5, CLC-4, CLC-7, and
KIF3B, and five KIF3B deletional constructs (Fig. 1), were subcloned
into pCMV-Myc and pCMV-HA, respectively (BD Bioscience), and
cotransfected into HEK293 or COS7 cells using FuGene 6 (Roche)
according to the manufacturer’s instructions. Cells were harvested
after 48 h, and lysed in mRIPA (50 mM Tris · HCl, pH 7.4, 150 mM
NaCl, 1 mM EDTA, 0.05% SDS, 1% Triton X-100), and supple-
mented with protease inhibitors (COMPLETE, Roche) and coimmu-
noprecipitation was performed using anti-Myc or -HA antibodies.
Protein complexes were captured with protein G sepharose beads,
eluted with Laemmli buffer, and analyzed by Western blot using
anti-Myc or HA antibodies as previously described (42). Endogenous
coimmunoprecipitation of CLC-5 and KIF3B was investigated using
a mouse whole kidney that was homogenized in mRIPA. Following
incubation at 4°C for 3 h, a supernatant fraction was obtained by
centrifugation at 12,000 g for 10 min at 4°C and used to investigate for
endogenous coimmunoprecipitation. To minimize nonspecific bind-
ing, the supernatant was preincubated for 1 h at 4°C with 50 l of
protein G sepharose beads (50% slurry). After centrifugation at
12,000 g for 1 min at 4°C, 1 g of CLC-5 polyclonal antibody (7),
KIF3B monoclonal antibody (BD Bioscience), or KAP3 monoclonal
antibody (BD Bioscience) was added to the supernatant, and the
sample was incubated overnight at 4°C. Protein complexes were
captured with protein G sepharose beads, eluted with Laemmli buffer,
and analyzed by Western blot using KIF3B, KIF3A, and KAP3
monoclonal antibodies (BD Bioscience).
Confocal imaging. KIF3B (FL) was subcloned into pEGFP-C and
CLC-5 (FL) with NH2 terminally tagged mRFP1 (monomeric red
fluorescent protein) (3) was subcloned into pcDNA 3.1/Myc-His.
HEK293 and/or COS7 cells were cotransfected with CLC-5 tagged
with red fluorescent protein (RFP) and/or KIF3B-GFP constructs,
using FuGene 6 (Roche). For Z-stack imaging, some CLC-5-RFP- and
KIF3B-GFP-cotransfected HEK293 cells, 24 h posttransfection, were
preextracted with a microtubule stabilizing buffer (MTSB; 80 mM
PIPES/KOH, pH 6.8, 1 mM MgCl, 5 mM EGTA, and 0.5% Triton
X-100 or 0.1% saponin) and fixed in 4% paraformaldehyde (PFA) or
ice-cold methanol. CLC-5-Myc-transfected OK cells, 24 h posttrans-
fection, and untransfected OK cells were preextracted with MTSB and
fixed in 4% PFA and coimmunostained using monoclonal anti-Myc
(Santa Cruz Biotechnology) and rabbit polyclonal anti-ZO1 (Invitro-
gen) or monoclonal anti-MAPRE1 (EB1; AbCam), which immunos-
tains the plus ends of microtubules (27), and rabbit polyclonal anti-
ZO1 (Invitrogen), which immunostains tight junctions of polarized
cells (27), and secondary antibodies anti-mouse Alexa Fluor 594 and
anti-rabbit Alexa Fluor 488 (Molecular Probes). Some RFP-tagged
CLC-5 cells, 24-h posttransfection, were fixed in 4% PFA and
immunostained using monoclonal anti-Kinesin-2 (Covance) or mono-
clonal anti--tubulin (Santa Cruz Biotechnology) and secondary an-
tibody anti-mouse Alexa Fluor 488 (Molecular Probes). The Z stacks
were recorded using a confocal laser-scanning microscope (Zeiss,
LSM 10 META) with a Plan-Achromat 63/1.4 oil DIC objective
(Carl Zeiss, Jena, Germany). An argon laser  	 458 nm and 488 nm
was used to excite enhanced green fluorescent protein (EGFP) and
Alexa Fluor 488 fluorescence, respectively. The mRFP1 was visual-
ized by a HeNe laser  	 543 nm. Emission of fluorescent proteins
and Alexa Fluor 488 was detected in the Multitrack mode in META
channels of the confocal system within the following spectral detec-
tion ranges: from 509 to 550 nm for EGFP, from 580 to 620 nm for
mRFP1 and Alexa Fluor 594, and from 509 to 550 nm for Alexa Fluor
488. The Zeiss confocal microscope and software automatically gen-
erate a merged image from the original images obtained in the separate
channels, thereby avoiding any errors or shifts that may arise from
manual editing. Colocalization was assessed by using these merged
images and by intensity profile line scans if there was a large
variability in the intensity of the subcellular structures. Peaks obtained
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from intensity profile line scans were considered to overlap and hence
indicate colocalization if the distance between them was 
300 nm,
which is the maximum approximate diameter of an endosomal vesicle
in the proximal renal tubule (19). For live cell imaging, cells were
observed 24 h posttransfection under a laser-scanning confocal mi-
croscope (Bio-Rad Radiance 2100) using a Nikon Fluor 60 water
immersion objective lens. Cells were perfused with extracellular
solution containing (in mM) 137 NaCl, 5.6 KCl, 1.2 MgCl2, 2.5
CaCl2, and 5 HEPES (pH 7.4 NaOH) at 34°C. HEK293 cells
transfected with CLC-5-RFP and KIF3B-GFP were treated with
nocodazole/DMSO (20 M/0.12%) or DMSO alone (0.12%) for 4 h
and fixed with 4% PFA. Microtubule restoration was verified by
washing in nocodazole free medium (14). GFP was excited using a
488-nm Ar/Kr laser and detected with a 515- to 530-nm emission
filter. mRFP1 was excited using a 543-nm green He-Ne laser and
detected with a 600-nm long pass filter. Simultaneous recordings were
made using a 560-nm dichroic mirror. Live cell scans were sampled
at 1 Hz using Lasersharp 2000 software (Bio-Rad Laboratories).
Electrophysiological studies. CLC-5 (FL) and KIF3B (FL) and
deletional constructs (Fig. 1) were subcloned into pEGFP-C and
pCMV-HA, respectively (BD Bioscience). The KIF3B-ATP construct
was generated by using site-directed mutagenesis (Quikchange, Strata-
gene) to alter the ATP/GTP-binding site motif from GQTGTGKT to
GQTGTAAT. HEK293 cells were transfected with CLC-5-GFP with
or without KIF3B (FL)-HA, or a KIF3B deletion construct, using
FuGene 6 (Roche). A threefold ratio of KIF3B to CLC-5 was used. In
addition, cells were transiently transfected with pSUPER (24) con-
taining a sequence for siRNA for KIF3B (GAAGCTACCAAGAT-
CAACC; KIF3B siRNA) or an unrelated control (i.e., nonsense)
sequence (control siRNA). The effects of the siRNA on protein
expression were assessed by Western blot analysis performed with
either an anti-KIF3B antibody (Santa Cruz Biotechnology), anti-
KIF3A antibody (BD Biosciences), or anti--tubulin antibody (Ab-
Cam). Densitometry of the Western blots was performed using a
GS-710 calibrated imaging densitometer and the Quantity One Sys-
tem Software (Bio-Rad Laboratories). Transfected cells were identi-
fied by EGFP epifluorescence. Patch pipettes were pulled from thin-
walled borosilicate glass (Harvard) and fire-polished. Electrode resis-
tances ranged from 1 to 3 M in the experimental solutions. Currents
were recorded using the whole cell patch-clamp configuration (70%
series-resistance compensation) with an EPC-10 amplifier and Patch-
master software (HEKA). Currents were filtered at 10 kHz and
digitized at 50 kHz. Cells were held at 30 mV and 10-ms pulses
from 100 to 200 mV were applied at 1-s intervals. A P/8
leak-subtraction protocol was used. The bath solution contained (in
mM) 140 CsCl, 1 CaCl2, 1 MgCl2, 10 HEPES, at pH 7.4. The pipette
solution contained 42 CsCl, 49 Cs2SO4, 10 EGTA, 10 HEPES, at pH
7.4. Recordings were analyzed using Fitmaster (HEKA) and Microcal
Origin 7.5 software. Conductance-voltage relationships were fitted
with the Boltzmann equation, G 	 Gmax/[1  exp(V0.5  V)/k], to
obtain values for Gmax.
Cell surface expression of CLC-5. Cell surface proteins were
biotinylated using an adaptation of a previously reported method (24).
Briefly, HEK293 or OK cells were transfected with CLC-5-Myc and
KIF3B-HA or siRNA constructs using FuGene 6 (Roche) or Lipo-
fectamine Plus (Invitrogen), grown to confluence, and cell surface
proteins were biotinylated with 1.22 mg/ml EZ-Link NHS-SS-Biotin
(Pierce) at room temperature with gentle agitation. Monolayers were
washed three times in cold phosphate-buffered saline, and the cells
were lysed in mRIPA. The biotinylated proteins were isolated by
binding to ImmunoPure immobilized Streptavidin (Pierce) for 1 h at
4°C. The beads were pelleted and the supernatant that contained the
cytosolic (unbiotinylated) fraction was recovered by centrifugation at
4,500 g for 6 min at 4°C. The membrane (biotinylated) fraction was
washed, and the pellet was resuspended in Laemmli sample buffer.
Proteins from the cytosolic (unbiotinylated) and cell surface (biotin-
ylated) fractions were resolved on SDS-polyacrylamide gel and trans-
ferred to PVDF membrane and Western blot analysis was performed
with an anti-Myc antibody (Santa Cruz Biotechnology). Densitometry
of the Western blots was performed using a GS-710 calibrated
imaging densitometer and the Quantity One System Software (Bio-
Rad Laboratories).
RT-PCR. PCR was performed on first-strand cDNA generated from
total RNA of HEK293 cells, OK cells, human kidney (Ambion
Europe), mouse kidney and mouse proximal renal tubular cells
(mPTCs) using avian myeloblastosis virus RT and primers specific for
cubilin, megalin, KIF3B, calmodulin, caveolin-1, caveolin-2, and
GAPDH (primer sequences available on request), using methods
previously described (42).
Albumin and transferrin uptake. Albumin and transferrin uptake
were measured using modifications of standard methods, as previ-
ously described (14, 26). HEK293 or OK cells were seeded in 24-well
plates and transiently transfected with empty vector or KIF3B (FL),
MD/CC, CC/GD, -ATP or siRNA constructs using FuGene 6 (Roche)
according to the manufacturer’s protocol and grown for 4 or 7 days,
respectively. To measure albumin uptake, cells were exposed to 50
g/ml of albumin conjugated to FITC, Alexa Fluor 594, or Texas Red
(Sigma or Molecular Probes) for 120 min. To measure transferrin
uptake, OK cells were exposed to 50 g/ml of transferrin conjugated
to Alexa Fluor 594 (Molecular Probes) for 20 min. Nonspecific
binding was determined in cells exposed to albumin or transferrin for
1 min. At the end of the uptake period, cells were washed in ice-cold
HEPES buffer, pH 6, and solubilized in MOPS lysis buffer (20 mM
MOPS, 0.1% Triton X-100, pH 7.4). The FITC, Texas Red, or Alexa
Fluor 594 fluorescence was determined using a CytoFluor microplate
reader (PerSeptive Biosystems) at 480-nm excitation and 520-nm
emission or 596-nm excitation and 615-nm emission wavelengths,
respectively. Total FITC/Texas Red-albumin or Alexa Fluor 594-
transferrin uptake was standardized to total cellular protein. For
competition experiments, HEK293 and OK cells were simultaneously
incubated with either 50 mg/ml unlabeled albumin or transferrin
during the endocytosis assay, and the uptake of fluorescently labeled
albumin or transferrin was compared with that without competition,
which was the reference value set at 100%.
Subcellular fractions from Clcn5Y/ kidneys. Mice were kept in
accordance with approved protocols by the Ethics Committee for
Animal Experimentation of the Université Catholique de Louvain
Medical School (Brussels) (Ref. no. UCL/MD/2006/036). The
Clcn5Y/ mice, generated by targeted deletion of the exon VI of
Clcn5, have been previously reported to have features of Dent’s
disease (4, 55). Kidneys from 15-wk-old Clcn5Y/ and Clcn5Y/ male
littermates were obtained. Subcellular fractions from these kidneys
were prepared and used for Western blot analysis as previously
reported (4). The samples were loaded as 20 g of total protein per
lane, as appropriate for subcellular fractionations (13). The following
antibodies were used: affinity-purified rabbit polyclonal antibodies
against the NH2 terminus of human CLC-5 (55), mouse monoclonal
antibodies against KIF3B (BD Bioscience), Rab5a (Santa Cruz Bio-
technology), goat polyclonal antibodies against cathepsin D (Santa
Cruz Biotechnology), mouse monoclonal antibodies (E11) against the
E1 subunit of V-ATPase (Dr. S. Gluck, University of California, San
Francisco, CA), and -actin (Sigma, St. Louis, MO). Specificity was
determined by incubation with nonimmune rabbit or mouse IgG
(Vector Laboratories, Burlingame, CA). Densitometry analysis was
performed with a Canon CanoScan8000F using the NIH Image V1.60
software.
mPTC primary cultures. Polarized and differentiated mPTC cul-
tures were prepared as described previously (51). Kidneys from
Clcn5Y/ and Clcn5Y/ mice aged 21–28 days were used to isolate
tubules, which were seeded onto collagen-coated PTFE filter mem-
branes in culture medium [DMEM:F12 with 15 mM HEPES, 0.55
mM Na-pyruvate, 0.1 ml/l nonessential amino acids, and the Single-
Quots Kit (Lonza) containing hydrocortisone, hEGF, FBS, epineph-
rine, insulin, triiodothyronine, transferrin, gentamicin/amphotericin,
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pH 7.4, and osmolality at 325 mosmol/kgH2O] and incubated in a
humidified chamber at 37°C and 5% CO2. After 3–4 days, at 60–
80% confluency, primary cell cultures were transfected with an
appropriate plasmid (1–2 g) using FuGene HD (Roche) or Lipo-
fectamine (Invitrogen). After 72 h, cells were analyzed by quantitative
PCR (qPCR) for the expression of KIF3B (human and mouse) and
KIF3A or an endocytosis assay was performed.
qPCR analyses. qPCR was performed as previously described (30).
Total RNA from mouse kidney or mPTC primary cultures was extracted
and reverse-transcribed into cDNA using SuperScript III RNase H Re-
verse Transcriptase (Invitrogen), using the following primers: KIF3B
(154 bp) sense 5=-GCCAAAATCAAGGCCATGGAGAGT-3= and antisense
5=-GACTCTCCATTTGCTGCTGGATTTC-3=, GAPDH (176 bp) sense 5=-
TGCACCACCAACTGCTTAGC-3= and antisense 5=-GGATGCAGGGAT-
GATGTTCT-3=. qPCR analyses were performed in duplicate using the
SYBR green fluorescence method, as previously reported (31). For
each assay, standard curves were prepared by serial fourfold
dilutions of mouse adult kidney cDNA. Calculations of primer
efficiencies [efficiency 	 (101/slope)  1] demonstrated that KIF3B
and GAPDH efficiencies were 0.92 0.04 and 1.02 0.03, respectively.
mRNA expression was investigated in four or more pairs of Clcn5Y/
and Clcn5Y/ mouse kidneys, or mPTC primary cultures, after normaliza-
tion to GAPDH: ratio	 2DCt (KOWT) KIF3B/2DCt (KOWT) GAPDH (44).
Endocytosis assay using mPTC cultures. Mock or KIF3B-trans-
fected mPTC cultures were washed with warm HBSS (37°C) after
which they were incubated with FITC-conjugated bovine serum
albumin at concentrations of 0.5 mg/ml for 15 min at 37°C. After the
incubation, mPTCs were washed five times with cold HBSS (4°C) and
lysis buffer was added. The fluorescence in the lysate was measured
using a fluorimeter (Perkin Elmer) with excitation at 490 10 nm and
emission at 525  10 nm. Fluorescence was normalized for the
amount of proteins in the primary cell cultures. Protein concentration
was measured using the BCA kit. For metabolic inhibition experi-
ments, mPTC cultures were incubated with 10 mM sodium azide or 50
mM 2-deoxyglucose (DOG) for 30 min at 37°C before the endocy-
tosis assay. For competition experiments, mPTC cultures were simul-
taneously incubated with 50 mM unlabeled albumin or transferrin
during the endocytosis assay.
Statistical analysis. Significance of differences was assessed by
unpaired, two-tailed Student’s t-test.
RESULTS
Yeast two-hybrid screen identifies KIF3B. Screening of an
adult human kidney cDNA library with the COOH terminus
of human CLC-5 (amino acids 551 to 746; Fig. 1A) as bait
identified a clone (c73) that coded for a COOH-terminal
fragment (amino acids 410 to 747) of a member of the
Kinesin superfamily, KIF3B (Fig. 1B) (21). KIF3B is a
microtubule-dependent motor protein that exists in a hetero-
trimeric complex, known as Kinesin-2, with KIF3A (Gen-
Bank accession number NM_007054.5) and Kinesin Asso-
ciated Protein 3 (KAP3; GenBank accession number
NM_014970.2) (5, 35). KIF3B has an NH2-terminal motor
domain (MD), a coiled-coil (CC) domain that dimerizes
with that of KIF3A, and a COOH-terminal globular domain
(GD), that in conjunction with KIF3A-GD binds KAP3.
KIF3B is coexpressed with KIF3A and KAP3 in the kidney,
and the function of Kinesin-2 as a microtubule-based fast
anterograde translocator of membranous organelles is con-
sistent with a role for the KIF3B and CLC-5 interaction in
endosomal trafficking (61).
Interaction between CLC-5 and KIF3B. To confirm that
KIF3B and CLC-5 interact directly, we performed further yeast
two-hybrid, GST pull-down, and coimmunoprecipitation studies
with full-length (FL) and deletional constructs (Fig. 1, B–E).
Coexpression of CLC-5 and KIF3B constructs in yeast cells was
confirmed by Western blot analysis (data not shown). Yeast
two-hybrid analysis showed that the CLC-5 COOH terminus and
FL KIF3B interacted (Fig. 1B). However, CLC-5 CBS1 and
CBS2 alone were not sufficient for the interaction with KIF3B
(FL). The interaction between the CLC-5 COOH terminus and the
CC and GD of KIF3B was confirmed by GST pulldown (Fig. 1C).
In addition, the interaction between CLC-5 and KIF3B was
established to occur in vivo, by demonstrating endogenous coim-
munoprecipitation of the two proteins in mouse whole kidney
extracts (Fig. 1D). KIF3B forms a Kinesin-2 complex, which
consists of KIF3A, KIF3B, and KAP3 (5, 35), and this was
confirmed to occur in the mouse whole kidney extracts by using
appropriate KIF3A, KIF3B, and KAP3 antibodies to demonstrate
endogenous coimmunoprecipitation (Fig. 1D). The structural ba-
sis of the CLC-5 and KIF3B interaction in mammalian cells was
further investigated by cotransfecting human embryonic kidney
(HEK293; Fig. 1E) and African green monkey kidney, COS7
cells (data not shown), with FL CLC-5 and KIF3B constructs that
were tagged with Myc and HA epitopes, respectively. When
Myc-CLC-5 was immunoprecipitated with anti-Myc antibody, the
immunoreactive band of KIF3B was detected in the immunopre-
cipitate. Myc-CLC-5 was reciprocally coimmunoprecipitated with
anti-HA antibody. The use of KIF3B deletion constructs contain-
ing the MD, CC, or GD alone or in combination (MD/CC and
CC/GD) demonstrated that the KIF3B CC and GD could interact
individually or as a fusion protein with CLC-5 (Fig. 1, E and F).
These results establish an interaction, in mammalian cells, be-
tween the CLC-5 COOH terminus and the fused CC and GD of
KIF3B. The COOH terminus and the CBS domains of CLCs are
highly conserved (11) and to assess the specificity of this inter-
action, the interactions between KIF3B and two other CLCs,
CLC-4 and CLC-7, were therefore investigated. CLC-4 and
CLC-7 were selected because one of them, CLC-4, has a COOH
terminus that is highly conserved with an amino acid identity of
73% and a similarity of 87% (BlastP) to that of the CLC-5 COOH
terminus, and CLC-7 has a COOH terminus that is less highly
conserved with a 27% identity and 49% similarity to that of the
CLC-5 COOH terminus. However, CLC-4 has a predominant role
in epithelial endosomal transport (40), whereas CLC-7 has a
predominant role in osteoclast late endosomal and lysosomal
transport (28). The interaction between KIF3B and CLC-4 and
CLC-7 was investigated by cotransfection of Myc-CLC-4 or
Myc-CLC-7 with HA-KIF3B in HEK293 cells (Fig. 1G). KIF3B
was detected in immunoprecipitates from both Myc-CLC-4- and
Myc-CLC-7-transfected cells when immunoprecipitated with anti-
Myc antibody. Both Myc-CLC-4 and Myc-CLC-7 were recip-
rocally immunoprecipitated with anti-HA antibody. These
findings indicate that there is a potential common trafficking
mechanism involving KIF3B and the COOH terminus of other
members of the CLC family.
CLC-5-containing vesicles are transported along KIF3B
microtubules. The basis of the CLC-5 and KIF3B interaction, in
mammalian cells, was further investigated by colocalization stud-
ies of CLC-5 and KIF3B using transient expression of fluores-
cently tagged CLC-5 and KIF3B in HEK293 and COS7 (data not
shown) cells. This revealed KIF3B to be mostly distributed in a
punctate pattern throughout the cytoplasm (Fig. 2A). KIF3B also
associated with tubulin (data not shown), and this microtubule-
like distribution and colocalization with tubulin are consistent
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with its presence on microtubules (61). CLC-5 was concen-
trated at the plasma membrane, and in punctate structures
throughout the cytoplasm, where it showed partial colocaliza-
tion with KIF3B (Fig. 2A). A detailed examination using
intensity profile line scan analysis in five cells helped to further
demonstrate the colocalization of CLC-5 and KIF3B. Thus, an
examination of 138 vesicles revealed that 68 vesicles expressed
both KIF3B and CLC-5, 42 vesicles expressed KIF3B only,
and 28 vesicles expressed CLC-5 only. Thus, of the 110
vesicles expressing KIF3B, 62% showed colocalization with
CLC-5, and of the 96 vesicles expressing CLC-5, 71%
showed colocalization with KIF3B. A mean (SE) of 14
(1.6) of the 28 (1.7) vesicles within a cell demonstrated
colocalization of CLC-5 with KIF3B, and the total cell area
occupied by each of KIF3B- and CLC-5-containing vesicles
within these cells was 3.4%. The observed frequency of
CLC-5 and KIF3B colocalization was significantly higher at
2.3% (P 
 0.001) than that expected to occur at random,
which is estimated to be 0.12% (i.e., 3.4% of 3.4%), thereby
indicating that the observed colocalization of CLC-5 and
KIF3B is 20-fold greater than that expected to occur by
chance alone. CLC-5 was also demonstrated to be associated
with microtubules by costaining with anti--tubulin (Fig.
2B) and to colocalize with the Kinesin-2 complex that
Fig. 2. Confocal microscopy shows colocalization of CLC-5 and KIF3B. HEK293 cells transfected with fluorescently tagged CLC-5 and KIF3B (CLC-5-RFP
and KIF3B-GFP) and costained with anti--tubulin or anti-Kinesin-2. A-C: Z-stack dual wavelength confocal microscopy. For each stack, images were obtained
in 2 channels over 15 horizontal planes that were 0.7 m apart. A: HEK293 cells transfected with KIF3B-GFP and CLC-5-RFP. Green signals: KIF3B; red
signals: CLC-5; yellow signals: colocalized KIF3B and CLC-5 (merge). Confocal Z-stack images and intensity profile line scans demonstrated that KIF3B-GFP
and CLC-5-RFP are partially colocalized, as evidenced by the yellow signals or by an overlap of
300 nm, which is the estimated diameter of a proximal tubular
endosomal vesicle (19), in the red and green peaks (confocal images 1 to 5). The intensity profile line scans were performed between the white crosses as indicated
on confocal images 1 to 5, with the intensity measured in arbitrary units (A.U.). Scale bar top: 10 m; scale bar confocal images 1 to 5: 2 m. B: HEK293 cells
transfected with CLC-5-RFP and costained with anti--tubulin. Red signals: CLC-5; green signals: tubulin; yellow signals: colocalized CLC-5 and tubulin
(merge). CLC-5-RFP was present at the plasma membrane and in punctate structures throughout the cytoplasm, where it was localized with tubulin, indicating
its association with microtubules. Scale bars: 10 m. C: HEK293 cells transfected with CLC-5-RFP and costained with anti-Kinesin-2 antibody. Red signals:
CLC-5; green signals: Kinesin-2; yellow signals: colocalized CLC-5 and Kinesin-2 (merge). Scale bars: 10 m. D and E: live cell imaging using dual-wavelength
confocal microscopy of HEK293 cells cotransfected with full-length CLC-5-RFP and full-length KIF3B-GFP. Green signals: KIF3B; red signals: CLC-5; yellow
signals: colocalized CLC-5 and KIF3B. Scale bar: 10 m. A proportion of CLC-5-RFP-labeled vesicles was transported along KIF3B-labeled cytoskeletal
network structures. E: progress of a vesicle (arrowed), over 10 s, is illustrated. The vesicles were estimated to move at an approximate rate of 0.42 m/s. Scale
bar: 5 m.
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contains KIF3B (Fig. 2C). In addition, the microtubular
location of CLC-5-containing vesicles and KIF3B was fur-
ther demonstrated by the use of nocodazole, which inhibits
polymerization of free tubulin molecules (14). The extent of
microtubule depolymerization after nocodazole treatment,
and restoration following nocodazole wash-out, was verified
by anti--tubulin staining. Nocodazole treatment of trans-
fected HEK293 cells resulted in a disruption of microtubule
integrity and a dramatic redistribution of CLC-5 and KIF3B
(data not shown).
Live cell imaging using cotransfected HEK293 and COS7
(data not shown) cells demonstrated that CLC-5-containing
vesicles were transported along the KIF3B-labeled cytoskel-
etal network structures (Fig. 2, D and E). These vesicles
Fig. 2—Continued
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were estimated to move at an approximate rate of 0.42 m/s.
Thus, KIF3B and CLC-5 colocalize within the cell, thereby
supporting the yeast two-hybrid and coimmunoprecipitation
data (Fig. 1, B–F), which indicate that the two proteins
physically interact.
Effects of CLC-5 and KIF3B interaction on chloride cur-
rents, cell surface CLC-5 expression, and CLC-5 internaliza-
tion in nonpolarized HEK293 cells. The functional significance
of the CLC-5 and KIF3B interaction was investigated further
by electrophysiological studies in HEK293 cells, which are a
nonpolarized but well-established mammalian cell system for
recording CLC-5 currents (12). Large, outwardly rectifying
whole cell currents were recorded from HEK293 cells trans-
fected with CLC-5 (Fig. 3A) or cotransfected with KIF3B (Fig.
3B), but not from untransfected cells (Fig. 3C). These currents
were strongly voltage dependent and activated at potentials
above 30 mV. The presence of KIF3B resulted in a 45%
increase in the amplitude of CLC-5 currents. The maximum
conductance (Gmax), which is a measure of antiporter density,
was significantly increased in cells coexpressing CLC-5 and
KIF3B (FL)-HA (30.4  3.2 nS, n 	 10), compared with cells
expressing CLC-5 and pCMV-HA alone (20.9  1.5 nS, n 	
5; P 
 0.02; Fig. 3D). This increase in membrane conductance
occurred without any effect on voltage-dependent gating.
These data demonstrated a specific and functional interaction
between CLC-5 and KIF3B and indicate a role for KIF3B in
regulating CLC-5 currents.
KIF3B forms a heterotrimeric complex with KIF3A and
KAP3, and the functional effects of KIF3B deletional con-
structs consisting of KIF3B MD/CC or KIF3B CC/GD and a
hydrolysis-deficient mutant (KIF3B-ATP) were assessed.
These constructs were particularly selected as they have been
reported to exert dominant-negative effects in dividing cells
(18). Coexpression of CLC-5 with the KIF3B MD/CC, CC/
GD, or -ATP constructs did not increase Gmax (n 	 10 each),
when compared with CLC-5 and pCMV-HA alone (n 	 10).
These results are in keeping with a dominant-negative effect in
which the mutant KIF3B proteins compete with the endoge-
nous normal KIF3B proteins for dimerization with the KIF3A
subunit. However, this requires cautious interpretation as the
effects of such dominant-negative constructs increase gradu-
ally with time, as they require incorporation into new Kine-
sin-2 heterotrimers before they can interfere with motility (2).
Thus, our results (Fig. 3D), which were observed at 48 h
posttransfection, may be consistent with this slow time course.
The increase in the amplitude and Gmax of CLC-5 currents
(Fig. 3D) observed when KIF3B was coexpressed could be
explained by an increased number of CLC-5 antiporters at the
cell surface. We investigated this possibility by using cell
surface biotinylation to determine any changes in surface levels
of CLC-5 in response to coexpression with KIF3B and its
deletional constructs (Fig. 3E). Each experimental protocol
was repeated five times on separate batches of cells. Coexpres-
sion of CLC-5 with KIF3B (FL)-HA in HEK293 cells caused
a significant increase in CLC-5 cell surface expression com-
pared with control HEK293 cells cotransfected with CLC-5
and pCMV-HA alone (n 	 5; P 
 0.02; Fig. 3E). Coexpres-
sion of CLC-5 with the KIF3B MD/CC, CC/GD, or -ATP
constructs revealed no significant effect on CLC-5 cell surface
expression when compared with CLC-5 and pCMV-HA alone
(Fig. 3E). These results demonstrate that the KIF3B-mediated
changes in CLC-5 currents were due to changes in cell surface
levels of the antiporter.
The increase in the cell surface levels of CLC-5 in response
to KIF3B overexpression in HEK293 cells could result either
from an increased delivery of CLC-5 to the surface or from a
decrease in CLC-5 internalization. However, in nonpolarized
cells, such as HEK293 cells, the microtubules are organized
with the positive ends toward the cell surface (Fig. 3F), and
hence KIF3B will be transporting its cargo anterogradely
toward the cell surface. Thus, overexpression of KIF3B in
HEK293 cells is predicted to increase the transport of CLC-5
toward the cell surface, and this is consistent with the observed
significant increase in CLC-5 currents and cell surface expres-
sion (Fig. 3, D and E). We further investigated the specificity
of the role of KIF3B in regulating CLC-5 currents and plasma
membrane levels by the use of siRNA. KIF3B was downregu-
lated with siRNA causing a reduction in protein levels to 51 
1.9% compared with control, i.e., nonsense siRNA (n	 4; P

0.03), whereas those of KIF3A and tubulin remained un-
changed (Fig. 3, G and H). Whole cell currents were measured
from HEK293 cells expressing CLC-5 alone or coexpressing
CLC-5 and KIF3B siRNA or control siRNA. The coexpression
of KIF3B siRNA significantly reduced Gmax from 22.8  2.2
nS (n 	 10) to 12.3  0.9 nS (n 	 9; P 
 0.001; Fig. 3I).
Coexpressing control siRNA had no significant effect on Gmax
(22.9  8 nS, n 	 10). To investigate whether this decrease in
conductance is due to decreased expression of antiporters at the
cell surface, we coexpressed CLC-5 with KIF3B siRNA and
found that there was a significant decrease in CLC-5 cell
surface expression compared with HEK293 cells cotransfected
with CLC-5 and control siRNA (n 	 6; P 
 0.01; Fig. 3J).
These results further demonstrate the functional interaction
between CLC-5 and KIF3B in regulating chloride currents and
CLC-5 cell surface expression.
Effects of CLC-5 and KIF3B interaction on albumin trans-
ferrin and endocytosis in nonpolarized HEK293 and polarized
OK cells. The data from the electrophysiological and biotiny-
lation studies showed that chloride currents (Fig. 3, D and I)
and the cell surface levels of CLC-5 (Fig. 3, E and J) could be
regulated by KIF3B in HEK293 cells. Cell surface levels of
CLC-5 are rate limiting for albumin uptake (25), and to further
assess the functional interaction between CLC-5 and KIF3B,
we initially investigated its effects on albumin uptake in
HEK293 cells. HEK293 cells, which have previously been
shown to express endogenous CLC-5 (7), were shown to have
endogenous expression of megalin and KIF3B, but not cubilin
(Fig. 3K). Thus, they could be used to study albumin uptake via
the megalin-dependent receptor-mediated pathway (4) but not
transferrin uptake, which specifically requires binding to cubi-
lin for its renal tubular reabsorption (34). HEK293 cells were
transfected with KIF3B (FL), pCMV-HA, KIF3B siRNA, or
control siRNA constructs. Coexpression of KIF3B (FL) signif-
icantly increased albumin uptake to 107  2% (n 	 4; P 

0.02) of control levels (Fig. 3L). The MD/CC, CC/GD, and
-ATP constructs had no significant effect (data not shown).
Moreover, in cells in which KIF3B was downregulated, albu-
min uptake was significantly reduced to 60  5% of control
levels (n	 6; P
 0.02; Fig. 3L). In addition, in HEK293 cells
transfected with KIF3B (FL), pCMV-HA, KIF3B siRNA, or
control siRNA constructs, the uptake of fluorescently labeled
albumin was significantly decreased (n 	 6; P 
 0.001) by
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Fig. 3. Electrophysiological, cell surface expression, and albumin uptake studies in nonpolarized HEK293 cells. A-C: representative current recording from a
HEK293 cell expressing CLC-5 (A), CLC-5 and KIF3B (B), and an untransfected HEK293 cell (C). D: maximum conductance measured from HEK293 cells
cotransfected with CLC-5 and expression plasmids as indicated. Coexpression of KIF3B (FL) significantly increased conductance. E: densitometric analysis of
CLC-5 in cell surface fractions. Coexpression of KIF3B (FL) significantly increased the cell surface expression of CLC-5. F: microtubule orientation in
nonpolarized HEK293 cells. G: representative Western blot analysis for KIF3B, KIF3A, and tubulin expression in cell lysates obtained from HEK293 cells
transfected with control or KIF3B siRNA. KIF3B siRNA suppressed endogenous KIF3B expression, whereas there was no effect on KIF3A and tubulin
expression. H: densitometric analysis of KIF3B expression in cell lysates obtained from HEK293 cells transfected with control or KIF3B siRNA. KIF3B siRNA
significantly reduced expression of endogenous KIF3B. I: maximum conductance measured from HEK293 cells cotransfected with CLC-5 and KIF3B siRNA
or control siRNA plasmids as indicated. KIF3B siRNA significantly decreased conductance compared with coexpression of CLC-5 with control siRNA.
J: densitometric analysis of CLC-5 in cell surface fractions. KIF3B siRNA significantly decreased the cell surface expression of CLC-5, compared with
coexpression of CLC-5 with control siRNA (n 	 6). K: RT-PCR analysis of cubilin, megalin, KIF3B, calmodulin (positive control), and water blank (negative
control) in HEK293 cells and control human kidney (hKid). L: albumin uptake in HEK293 cells transfected with KIF3B constructs. KIF3B (FL) significantly
increased albumin uptake, whereas KIF3B siRNA significantly decreased albumin uptake, compared with their respective controls. M: competition assays for
albumin uptake. HEK293 cells were transfected with KIF3B constructs, in the absence (no competition) or presence (albumin competition) of excess unlabeled
albumin, and the uptake of fluorescently labeled albumin measured (n 	 6); the uptake of fluorescently labeled albumin without competition was taken as the
reference and set at 100% and compared with that obtained with competition using unlabeled albumin. Endocytosis of the fluorescently labeled albumin was
significantly reduced by competition with unlabeled albumin. Means 1 SE and P values calculated by Student’s unpaired, 2-tailed t-test are shown. *P
 0.02,
**P 
 0.01, and ***P 
 0.001.
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incubation in the presence of excess unlabeled albumin (Fig.
3M), indicating that the albumin uptake involves a receptor-
mediated pathway. Thus, these results are in agreement with
those of the electrophysiology and biotinylation studies and
further demonstrate the functional interaction between CLC-5
and KIF3B. These results clearly show that KIF3B is a specific
physiological regulator of constitutive receptor-mediated albu-
min uptake in HEK293 cells.
However, HEK293 cells are nonpolarized cells and have
their microtubules organized with the positive ends toward the
cell surface (Fig. 3F), whereas in polarized renal epithelial
cells the microtubules are organized with their minus ends
toward the apical surface and their plus ends extending through
the cell body to the basolateral surface (Fig. 4A). Moreover,
HEK293 cells do not express cubilin (Fig. 3K) and hence
cannot be used to study endocytosis of other molecules such as
transferrin. We therefore investigated the effects of KIF3B-
altered expression on the cell surface expression and internal-
ization of CLC-5 and their consequences for albumin and
transferrin uptake in polarized monolayers of OK cells. OK
cells are a representative model for renal proximal tubular cells
and have been reported to express megalin, cubilin, and CLC-5
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(7, 62), which facilitate receptor-mediated endocytosis of al-
bumin and transferrin (54). Albumin is a ligand for both
megalin and cubilin, whereas transferrin is a ligand for cubilin
only (54). To investigate further the role of the CLC-5 and
KIF3B interaction in polarized renal epithelial cells, we first
established that the OK cells were polarized in culture (Fig.
4B) and that they also expressed KIF3B (Fig. 4C). OK cells
were shown to be polarized in culture by demonstrating the
presence of ZO-1-immunostained tight junctions and the pres-
ence of microtubules that were orientated with their plus ends
extending through the cell body to the basolateral surface, as
demonstrated by basolateral expression of EB1 (Fig. 4B). OK
cells were also shown to endogenously express KIF3B (Fig.
4C), which could be significantly downregulated with KIF3B
siRNA, causing a reduction in protein levels to 55  4.3%,
compared with control (n 	 4; P 
 0.05; Fig. 4, D and E).
Finally, we demonstrated that Myc-tagged CLC-5 expression
in these polarized OK cells occurred at the apical cell surface
(Fig. 4F) and that the Myc epitope was not associated with
aberrant sorting of the Myc-tagged CLC-5 to the basolateral
membrane. The orientation of the microtubules (Fig. 4, A and
B) would predict that overexpression of KIF3B would result in
a decrease in the apical cell surface expression of CLC-5 and
an increase in CLC-5 endocytosis. Indeed, this is the case as
coexpression of CLC-5 with KIF3B (FL)-HA in OK cells
caused a significant decrease in CLC-5 cell surface expression
compared with control OK cells transfected with CLC-5 and
pCMV-HA alone (n 	 9; P 
 0.02; Fig. 4G). These results
indicate that when KIF3B is overexpressed in polarized (OK)
cells, anterograde transport of CLC-5-containing vesicles away
from the cell surface is increased, thereby reducing the number
of CLC-5 antiporters at the cell surface. This would be pre-
dicted to reduce albumin and transferrin uptake by the recep-
tor-mediated pathway that involves the megalin-cubilin recep-
tor complex (54), and we tested this hypothesis by transfecting
OK cells with KIF3B (FL)-HA, or pCMV-HA alone con-
structs. In addition, we investigated the effects of KIF3B
downregulation in OK cells, by use of KIF3B siRNA or control
siRNA constructs. Overexpression of KIF3B (FL) significantly
reduced albumin uptake to 83  4% of control levels (n 	 6;
P 
 0.02), whereas downregulation of KIF3B significantly
increased albumin uptake to 107 2% (n	 12; P
 0.05; Fig.
4H). Overexpression of KIF3B (FL) also significantly reduced
transferrin uptake to 87  3% (n 	 6; P 
 0.05) of control
levels, whereas downregulation of KIF3B significantly in-
creased transferrin uptake to 111  3% of control levels (n 	
12; P
 0.05; Fig. 4I). In addition, in OK cells transfected with
KIF3B (FL), pCMV-HA, KIF3B siRNA, or control siRNA
constructs, the uptake of fluorescently labeled albumin was
significantly decreased by incubation in the presence of excess
unlabeled albumin or unlabeled transferrin (n 	 6; P 
 0.001;
Fig. 4J). Similarly, the uptake of fluorescently labeled trans-
ferrin was significantly decreased by incubation in the presence
of excess unlabeled albumin or unlabeled transferrin (n 	 6;
P 
 0.001; Fig. 4K). These combined data demonstrate that
excess of albumin will block the available binding sites on the
megalin-cubilin receptor complex and therefore decrease the
endocytosis of fluorescently labeled albumin and transferrin;
similarly, an excess of transferrin will block the available
binding site on cubilin and therefore decrease endocytosis of
fluorescently labeled albumin and transferrin. Thus, these re-
sults demonstrate that KIF3B is a specific physiological regu-
lator of constitutive albumin and transferrin uptake in polarized
OK cells via a receptor-mediated pathway that involves the
megalin-cubilin receptor complex.
Clc-5 and Kif3b interaction studies in Clcn5Y/ and
Clcn5Y/ mouse kidneys. The cellular studies (Figs. 1–4)
establish that CLC-5 and KIF3B interact and that this interac-
tion is important for the cell surface expression of CLC-5,
CLC-5 currents, and in facilitating endocytosis of albumin and
transferrin. To demonstrate further the CLC-5 and KIF3B
interaction and its role in endocytosis, we undertook studies
using kidneys from normal male mice (Clcn5Y/) and mutant
male mice deleted for Clcn5 (Clcn5Y/). A lack of Clc-5 in
Clcn5Y/ kidneys resulted in significantly increased Kif3b
mRNA and protein expression, as assessed by qPCR (Fig. 5A)
Fig. 4. Cell surface expression, albumin endocytosis, and transferrin endocytosis studies in polarized opossum kidney (OK) cells. A: microtubule orientation in
polarized OK cells [apical membrane (APM) and basolateral membrane (BLM)]. B: confocal microscopy of polarized OK cells stained with ZO1 (green) and
EB1 (red). Top: XY image. Bottom: single orthogonal view of ZO1 and EB1. OK cells were polarized in culture as evidenced by the presence of tight junctions
(green). In addition, numerous EB1-labeled microtubules are observed below the tight junctions demonstrating that the growing ends of microtubules are
predominantly at the basolateral surface of polarized OK cells. Scale bar 	 10 m. C: RT-PCR analysis of KIF3B and calmodulin (positive control) expression
in OK and HEK293 cells. A water blank was used as the negative control. OK cells have previously been shown to express CLC-5, megalin, and cubilin (7, 62).
D: representative Western blot analysis for KIF3B, KIF3A, and tubulin expression in cell lysates obtained from OK cells transfected with control or KIF3B
siRNA. KIF3B siRNA suppressed endogenous KIF3B expression, whereas there was no effect on KIF3A and tubulin expression. E: densitometric analysis of
KIF3B expression in cell lysates obtained from OK cells transfected with control or KIF3B siRNA. KIF3B siRNA significantly reduced expression of endogenous
KIF3B to 55  4.3%, compared with control, i.e., nonsense siRNA (n 	 4). F: confocal microscopy of polarized OK cells transfected with CLC-5-Myc and
stained with anti-Myc (red) and anti-ZO1 (green). Top: XY image. Bottom: single orthogonal view of CLC-5-Myc and ZO1. CLC-5-Myc-labeled structures can
be observed above the tight junctions (green) demonstrating expression of CLC-5-Myc predominantly at the apical surface of polarized OK cells. Scale bar 	
10 m. G: CLC-5 plasma membrane expression in OK cells (densitometric analysis after surface biotinylation). KIF3B (FL) significantly decreased the cell
surface expression of CLC-5, compared with coexpression of CLC-5 with pCMV-HA alone (HA; n 	 9). H: albumin uptake in OK cells transfected with KIF3B
constructs. KIF3B (FL) significantly decreased albumin uptake (n 	 6), compared with expression of pCMV-HA alone (HA), whereas KIF3B siRNA
significantly increased albumin uptake, compared with expression of control siRNA (n	 12). I: transferrin uptake in OK cells transfected with KIF3B constructs.
KIF3B (FL) significantly decreased transferrin uptake (n 	 6), compared with expression of pCMV-HA alone (HA), whereas KIF3B siRNA significantly
increased transferrin uptake (n 	 12), compared with expression of control siRNA. J: competition assays for albumin uptake. OK cells were transfected with
KIF3B constructs, in the absence (no competition) or presence (competition) of excess unlabeled albumin and transferrin, and the uptake of fluorescently labeled
albumin was measured. Endocytosis of fluorescently labeled albumin was significantly reduced by competition with either unlabeled albumin or unlabeled
transferrin (n 	 6). K: competition assays for transferrin uptake. OK cells were transfected with KIF3B constructs, in the absence (no competition) or presence
(competition) of excess unlabeled albumin and transferrin, and the uptake of fluorescently labeled transferrin was measured. Endocytosis of fluorescently labeled
transferrin was significantly reduced by competition with either unlabeled albumin or unlabeled transferrin (n 	 6). Means  1 SE and P values calculated by
Student’s unpaired, 2-tailed t-test are shown; *P 
 0.05, **P 
 0.02, $P 
 0.001.
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and Western blot analysis (Fig. 5, B and C). Investigations of
subcellular fractionations of kidneys from Clcn5Y/ and
Clcn5Y/ mice revealed that Kif3b was abundantly present in
the low-speed pellet and to a lesser extent also in the high-
speed pellet (Fig. 5D). Interestingly, whereas the high-speed
supernatant (cytosol) of wild-type mice kidneys showed no
detectable signal for Kif3b, this band was detected in Clcn5Y/
mouse kidneys, indicating a defect of recruitment with sedi-
mentable material. This altered subcellular distribution of
Kif3b in Clcn5Y/ mice, which was confirmed by densitometry
(data not shown), may be a reflection of the increased expres-
sion of Kif3b associated with a loss of Clc-5. Further analysis
of the high-speed pellet by isopycnic centrifugation revealed
that Kif3b equilibrated at low density, partly overlapping with
the endosomal markers Rab5a and the V-ATPase E1 subunit
and partially with Clc-5, but was fully resolved from the
lysosomal marker cathepsin D (Fig. 5, E and F). Thus, these
data support a significant association of Kif3b with Clc-5 and
endosomes.
To study further the role of the CLC-5 and KIF3B interac-
tion in albumin endocytosis, primary cell cultures of mPTCs,
which are polarized and differentiated (13), were prepared
from the kidneys of Clcn5Y/ and Clcn5Y/ mice, as described
previously (51). qPCR analysis using RNA from these mPTCs
revealed that endogenous Kif3b expression was significantly
higher in the mPTCs of Clcn5Y/ mice (Fig. 6A). This finding
is consistent with the observations of increased Kif3b expres-
sion in whole kidney extracts from Clcn5Y/ mice (Fig. 5,
A–D). Fluorescently labeled albumin endocytosis in the ab-
sence or presence of excess unlabeled albumin or transferrin
was investigated in Clcn5Y/ and Clcn5Y/ mPTCs that were
either untransfected or transfected with human GFP-tagged
KIF3B (Figs. 6, B and C). The transfection efficiency of human
KIF3B (hKIF3B) in mPTCs, as assessed by GFP expression,
was 40% in mPTC cultures from both Clcn5Y/ and
Clcn5Y/ mice (data not shown), and hKIF3B expression, as
assessed by qPCR, in the transfected mPTCs was 3,000-fold
higher than the endogenous mouse Kif3b and Kif3a (Fig. 6B).
Studies of albumin uptake, in these polarized cells, revealed a
strong decrease in mPTCs of Clcn5Y/ mice compared with
mPTCs of Clcn5Y/ mice (Fig. 6C). The residual uptake of
FITC-BSA in Clcn5Y/ cells may indicate that Clc-5 strongly
promotes but is not absolutely essential for receptor-mediated
endocytosis. Alternatively, these observations may reflect a
Clc-5-independent endocytic pathway, such as caveolin-depen-
dent endocytosis. Indeed, caveolin-1 and caveolin-2 were
shown to be expressed in HEK293 and OK cells, mouse
kidney, and mPTCs (Fig. 6D), and expression of caveolin-2
Fig. 5. Expression level and subcellular dis-
tribution of Kif3b in Clcn5Y/ and Clcn5Y/
mouse kidneys. A: quantitative PCR (qPCR)
of mRNA in Clcn5Y/ and Clcn5Y/ kidneys
(n 	 4 in each group). Kif3b mRNA levels
(adjusted to GAPDH mRNA) are signifi-
cantly higher in Clcn5Y/ than control kid-
neys (155  11%; *P 
 0.05). B: represen-
tative Western blot for Kif3b in Clcn5Y/
and Clcn5Y/ kidneys (n	 4 in each group),
using 20 g of protein. C: densitometric
analysis normalized to -actin levels con-
firms that Kif3b protein is more abundant in
Clcn5Y/ kidneys (153  19% of Clcn5Y/
level; *P
 0.05). D: representative Western
blot for Kif3b in low-speed (LS), high-speed
(HS) membrane, and cytosolic (C) fractions
of Clcn5Y/ and Clcn5Y/ kidneys. The
samples were loaded at 20 g total protein
per lane, as appropriate for subcellular frac-
tionations (13). Kif3b is detected in the cy-
tosol of Clcn5Y/ samples but not in con-
trols. E and F: density distribution after cen-
trifugation of the HS (membrane) fraction,
using a Percoll gradient, is presented com-
pared with the initial concentration (C/Ci),
so that values 1 reflect organelle enrich-
ment and values 
1 reflect organelle deple-
tion. This gradient resolves a low-density
peak (fractions 2–4), including early endo-
somes (Rab5a, V-ATPase), from a high-
density peak (fractions 9–10), enriched in
lysosomes (cathepsin D). Kif3b partially over-
laps with V-ATPase E1 subunit (low-density
fractions 2–3) and Clc-5 (fraction 3), which
supports their association with endosomes (F).
Means  1 SE and P values were calculated
by the Student’s unpaired, 2-tailed t-test.
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has been reported to be increased in Clcn5Y/ proximal tubules
(57). In both Clcn5Y/ and Clcn5Y/ mPTCs, fluorescently
labeled albumin endocytosis was reduced by competition with
excess unlabeled albumin and transferrin. These findings are
similar to those obtained using the polarized OK cells (Figs. 4,
J and K), and consistent with a role of CLC-5 and KIF3B
interaction in facilitating endocytosis via the megalin-cubilin
receptor complex (54, 57). Thus, an excess of albumin will
block the available binding sites on megalin and cubilin and an
excess of transferrin will block the available binding sites on
cubilin, and both will therefore decrease endocytosis of fluo-
rescently labeled albumin. In addition, this endocytosis by the
mPTCs of Clcn5Y/ and Clcn5Y/ mice was essentially abro-
gated by treatment with DOG and sodium azide (NaN3), which
block the production of ATP from glycolysis and oxidative
phosphorylation, respectively, and hence lead to energy deple-
tion in the cells (50). In Clcn5Y/ mPTCs, overexpression of
hKIF3B induced a strong decrease in the uptake of FITC-BSA,
but not complete abolishment, as evidenced by the residual
level of endocytosis that was reduced by competition with
albumin and transferrin excess, or metabolic inhibition (Fig.
6C). However, in Clcn5Y/ mPTCs, hKIF3B overexpression
completely abrogated endocytosis down to the level achieved
by energy depletion (Fig. 6C). This further suppression of
albumin endocytosis by hKIF3B overexpression in the CLC-
5-deficient mPTCs indicates that the level of Clc-5 expression
influences the effects of KIF3B on albumin endocytosis, and
this is consistent with the role of KIF3B in the intracellular
trafficking of other membranous organelles (61), such as
caveolae, which involves the Kinesin-2 complex (41). Thus,
the greater inhibitory effect on FITC-BSA endocytosis ob-
served on hKIF3B overexpression in the absence of Clc-5
indicates that the effects on endocytosis of KIF3B alterations
are dependent on Clc-5 expression.
DISCUSSION
Our results establish an interaction between CLC-5 and
KIF3B that is important for the plasma membrane expression
of CLC-5, microtubular transport of CLC-5 vesicles, and for
albumin uptake in polarized and nonpolarized cells. Thus, in
polarized epithelial cells such as OK cells, the interaction
Fig. 6. Endogenous Kif3b expression and albumin endocytosis in mouse proximal renal tubular primary cell cultures (mPTCs). A: endogenous expression of
Kif3b in mPTC cultures from Clcn5Y/ and Clcn5Y/ mice. The expression of Kif3b was determined by qPCR and was found to be significantly higher in the
Clcn5Y/ mice and consistent with the observations from mouse whole kidney extracts (Fig. 5A). B: expression of human KIF3B (hKIF3B) in transfected mPTCs
from Clcn5Y/ (n 	 3) and Clcn5Y/ (n 	 3) mice was assessed by qPCR and this showed an 3,000-fold higher expression of the exogenous human KIF3B,
compared with the endogenous expression of Kif3b [Kif3b(m)] and Kif3a. C: uptake of FITC-albumin in mPTC cultures from Clcn5Y/ and Clcn5Y/ mice in
mock-transfected cells, in the absence or presence of competition by excess unlabeled albumin and transferrin, or after energy depletion by deoxyglucose (DOG)
and sodium azide (NaN3), or in KIF3B-transfected cells. In Clcn5Y/ mPTCs, overexpression of hKIF3B decreases specific albumin endocytic uptake. In
Clcn5Y/ mPTCs, albumin uptake is fully abrogated (to the level of metabolic inhibition and albumin competition) by hKIF3B overexpression. D: RT-PCR
analyses of caveolin-1 (Cav-1) and caveolin-2 (Cav-2) in HEK293 cells, OK cells, Clcn5Y/ and Clcn5Y/ whole mouse kidneys, and Clcn5Y/ and Clcn5Y/
mPTCs. GAPDH and a water blank were used as positive and negative controls, respectively. Means  1 SE and P values were calculated by the Student’s
unpaired, 2-tailed t-test.
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between CLC-5 and KIF3B results in a reduction in the number
of antiporters at the cell surface, as KIF3B is involved in
facilitating microtubular transport that removes CLC-5-con-
taining vesicles from the cell surface (Fig. 7). In nonpolarized
cells, such as HEK293 cells, the orientation of the microtubules
is reversed (Fig. 3F), and the interaction between CLC-5 and
KIF3B facilitates transport of CLC-5-containing vesicles to the
cell surface. This situation may be analogous to that reported
for the interaction between CLC-2 and the microtubule-asso-
ciated dynein motor complex, which is also involved in regu-
lating CLC-2 cell surface expression through endosomal traf-
ficking (8). However, CLC-2 is ubiquitously expressed,
whereas CLC-5 is predominantly expressed in the kidney and
extrapolations between these two situations may require cau-
tious interpretation. In the kidney, CLC-5 plays an obligate role
in facilitating albumin uptake by the proximal tubule (7, 47),
where the cell surface availability of CLC-5 could be predicted
to be a rate-limiting step in albumin uptake. Indeed, the marked
reduction of albumin uptake by mPTCs of CLC-5-deficient
mice (Fig. 6C) is consistent with an important role for CLC-5
in albumin endocytosis. However, the polarized mPTCs from
CLC-5-deficient mice are capable of albumin uptake, although
at a reduced level. This residual albumin endocytosis is un-
likely to be due to compensation by CLC-4, since previous
experiments in CLC-5-deficient mPTCs have shown no further
reduction in albumin uptake after removal of Cl ions and
inhibition of endosomal acidification (56). This indicates the
presence of an alternate CLC-5-independent albumin uptake
pathway in mPTCs, whose activity could be altered by KIF3B
expression (Fig. 6C). Such an alternative albumin uptake
pathway may involve caveolin-1 and caveolin-2, which facil-
itate albumin transcytosis (29, 38). Moreover, it has been
suggested that caveolar transport involves the Kinesin-2 com-
plex (41) and this may provide a possible explanation for the
observed reduction in albumin uptake in the mPTCs from the
Clcn5Y/ mice (Fig. 6C), although it is important to note that
caveolae are not present at the apical surface of renal epithelial
cells (53). However, movement of caveolin-1, which is ex-
pressed at the apical membrane of renal epithelial cells (36), is
disrupted and ceases following treatment with nocodazole (41)
and this is similar to our findings of CLC-5 vesicle disruption
following nocodazole treatment. In this endocytic process, the
Kinesin-2 complex, which consists of KIF3A, KIF3B, and
KAP3 that are all expressed in renal epithelial cells, works as
a motor for anterograde transport along the microtubules to-
ward their plus ends (17, 21, 60, 61). In renal epithelial cells,
such as OK cells, the microtubules are organized longitudinally
with the plus end pointing toward the basolateral surface (Fig.
4A) (17, 21). Thus, vesicles that form part of the megalin-
cubilin receptor-mediated endocytic pathway (4, 7) and contain
CLC-5, via its interaction with KIF3B, will be transported
away from the apical membrane and toward the basolateral
membrane (Figs. 4A and 7). In our proposed working model for
the role of the CLC-5 and KIF3B interaction in endosomal
transport, CLC-5 mutations leading to a loss of the CLC-5 and
KIF3B interaction will result in a defective microtubular trans-
port of the endocytic vesicles that contain megalin and cubilin,
and this in turn will lead to the resorptive abnormalities of
solutes and proteins observed in Dent’s disease (4, 47).
The importance of the interaction between the CLC-5
COOH terminus and KIF3B is underscored by the observation
that 60% of CLC-5 mutations causing Dent‘s disease are
associated with a loss of the CLC-5 COOH terminus (58).
Furthermore, this microtubule-dependent vesicle transport is
likely to be an important contributor to protein endocytosis in
the kidney, as nocodazole has been shown to reduce, by 50%,
the apical endocytosis of albumin in OK cells (14). The
defective protein endocytosis due to mutations of the antiporter
CLC-5, which cause Dent’s disease, has been attributed to
impaired endosomal acidification secondary to a loss of chlo-
ride transport (4, 7, 16, 47, 55). However, our results show that
the mechanism underlying this defect in endocytosis may also
involve the interaction between CLC-5 and KIF3B, which
facilitates microtubular transport of endocytic vesicles (Fig. 7).
Fig. 7. Schematic representation of a working model for endosomal transport
involving CLC-5 and KIF3B interaction in polarized cells. CLC-5 and KIF3B
are expressed in polarized renal proximal tubular cells which reabsorb proteins
and solutes via the receptor-mediated endocytic pathway that uses megalin and
cubilin as the apical plasma membrane (APM) receptors (4, 7, 17). Ligands
bind to these receptors at the APM where CLC-5 and interacting proteins
Nedd4-2, NHERF2, and cofilin are also present (23, 24, 26). The receptor-
ligand complex is internalized in vesicles, containing CLC-5 and CLC-4 (40),
which are anterogradely transported along microtubules via the Kinesin-2
complex (17). These vesicles fuse with early endosomes where acidification
involves the vacuolar H-ATPase, with counter ions being provided by CLC-5
(28). In nonpolarized cells, the orientation of the microtubules is reversed (Fig.
3F), and CLC-5 vesicles would be transported to the cell surface.
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The COOH terminus of the family of nine mammalian CLCs
(CLC-1 to CLC-7, CLC-Ka, and CLC-Kb) is highly conserved
and includes the two CBS domains (11). The CLCs and
Kinesin family members are also expressed in multiple tissues
(17, 28), including the kidney and brain (43). These features
indicate that interactions between other CLCs and Kinesin
family members may be involved in endosomal trafficking and
microtubule-dependent transport in other tissues (43), and the
findings of our study may have implications for other renal,
neural, retinal, muscular, and skeletal disorders associated with
CLC mutations (22, 28, 32). The likelihood of such interac-
tions between CLCs and Kinesin family members and their
role in associated diseases is high as it has been established that
other transmembrane channels (e.g., the transient receptor
protein polycystin-2 and polycystin-2), transporter proteins
(e.g., the cystic fibrosis transmembrane regulator and sodium-
phosphate cotransporter type IIa), and exchangers (e.g., the
sodium-hydrogen exchanger, NHE3) can form functional in-
teractions with intracellular proteins (e.g., the phosphofurin
acidic cluster sorting protein, Kinesin-2, NHERF1/2, merlin-
ezrin-moesin, and myosin VIIb) and that these interactions can
have a vital impact on their physiological activity (9, 15, 20,
33, 59).
In summary, our studies show that CLC-5 and KIF3B
directly interact in vivo and this interaction involves the COOH
terminus of CLC-5 and the CC and GDs of KIF3B. The
interaction with KIF3B alters CLC-5 cell surface expression,
whole cell chloride current amplitudes, and is associated with
altered albumin endocytosis. The role of the interaction with
KIF3B is to facilitate microtubular transport and endocytosis of
CLC-5-containing vesicles away from the cell surface of po-
larized epithelial cells. Thus, our findings, which represent a
novel mechanism of ion channel and transporter regulation,
have elucidated that an interaction between CLC-5 and KIF3B
is important for the plasma membrane expression of CLC-5,
and for the microtubular transport of endosomes.
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